1
|
Fauser BC, Tarlatzis BC, Rebar RW, Legro
RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, et
al: Consensus on women's health aspects of polycystic ovary
syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS
Consensus Workshop Group. Fertil Steril. 97:28–38.e25. 2012.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Abbott DH, Tarantal AF and Dumesic DA:
Fetal, infant, adolescent and adult phenotypes of polycystic ovary
syndrome in prenatally androgenized female rhesus monkeys. Am J
Primatol. 71:776–784. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Jones GL, Hall JM, Balen AH and Ledger WL:
Health-related quality of life measurement in women with polycystic
ovary syndrome: A systematic review. Human Reprod Update. 14:15–25.
2008. View Article : Google Scholar
|
4
|
Jeanes YM and Reeves S: Metabolic
consequences of obesity and insulin resistance in polycystic ovary
syndrome: Diagnostic and methodological challenges. Nutr Res Rev.
30:97–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
5
|
Lauretta R, Lanzolla G, Vici P, Mariani L,
Moretti C and Appetecchia M: Insulin-sensitizers, polycystic ovary
syndrome and gynaecological cancer risk. Int J Endocrinol.
2016:86717622016. View Article : Google Scholar : PubMed/NCBI
|
6
|
De Leo V, Musacchio MC, Cappelli V,
Massaro MG, Morgante G and Petraglia F: Genetic, hormonal and
metabolic aspects of PCOS: An update. Reprod Biol Endocrinol.
14:382016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Rocca ML, Venturella R, Mocciaro R, Di
Cello A, Sacchinelli A, Russo V, Trapasso S, Zullo F and Morelli M:
Polycystic ovary syndrome: Chemical pharmacotherapy. Expert Opin
Pharmacother. 16:1369–1393. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Saeed R, Akram J, Changezi HU and Saeed M:
Treatment of hirsutism in polycystic ovarian syndrome with Diane,
50 mcg ethinyl estradiol and 2 mg cyproterone acetate. Specialist.
9:109–112. 1993.
|
9
|
Jing Z, Liang-Zhi X, Tai-Xiang W, Ying T
and Yu-Jian J: The effects of Diane-35 and metformin in treatment
of polycystic ovary syndrome: An updated systematic review. Gynecol
Endocrinol. 24:590–600. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Huang Y, Li W, Wang CC, Wu X and Zheng J:
Cryptotanshinone reverses ovarian insulin resistance in mice
through activation of insulin signaling and the regulation of
glucose transporters and hormone synthesizing enzymes. Fertil
Steril. 102:589–596.e4. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Li P, Wang GJ, Li J, Hao HP and Zheng CN:
Identification of tanshinone IIA metabolites in rat liver
microsomes by liquid chromatography-tandem mass spectrometry. J
Chromatogr A. 1104:366–369. 2006. View Article : Google Scholar : PubMed/NCBI
|
12
|
Chen Z and Xu H: Anti-inflammatory and
immunomodulatory mechanism of tanshinone IIA for atherosclerosis.
Evid Based Complement Alternat Med. 2014:2679762014. View Article : Google Scholar : PubMed/NCBI
|
13
|
Wang ZY, Liu JG, Li H and Yang HM:
Pharmacological effects of active components of chinese herbal
medicine in the treatment of Alzheimer's disease: A review. Am J
Chin Med. 44:1525–1541. 2016. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chapman JC, Min SH, Freeh SM and Michael
SD: The estrogen-injected female mouse: New insight into the
etiology of PCOS. Reprod Biol Endocrinol. 7:472009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Goldman JM, Murr AS and Cooper RL: The
rodent estrous cycle: Characterization of vaginal cytology and its
utility in toxicological studies. Birth Defects Res B Dev Reprod
Toxicol. 80:84–97. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Caldwell AS, Middleton LJ, Jimenez M,
Desai R, McMahon AC, Allan CM, Handelsman DJ and Walters K:
Characterization of reproductive, metabolic, and endocrine features
of polycystic ovary syndrome in female hyperandrogenic mouse
models. Endocrinology. 155:3146–3159. 2014. View Article : Google Scholar : PubMed/NCBI
|
17
|
Myers M, Britt KL, Wreford NG, Ebling FJ
and Kerr JB: Methods for quantifying follicular numbers within the
mouse ovary. Reproduction. 127:569–580. 2004. View Article : Google Scholar : PubMed/NCBI
|
18
|
Glidewell-Kenney C, Hurley LA, Pfaff L,
Weiss J, Levine JE and Jameson JL: Nonclassical estrogen receptor
alpha signaling mediates negative feedback in the female mouse
reproductive axis. Proc Natl Acad Sci USA. 104:8173–8177. 2007.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Liang N, Xu Y, Yin Y, Yao G, Tian H, Wang
G, Lian J, Wang Y and Sun F: Steroidogenic Factor-1 is required for
TGF-β3-mediated 17β-estradiol synthesis in mouse ovarian granulosa
cells. Endocrinology. 152:3213–3225. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Simpson ER and Davis SR: Minireview:
Aromatase and the regulation of estrogen biosynthesis-some new
perspectives. Endocrinology. 142:4589–4594. 2001. View Article : Google Scholar : PubMed/NCBI
|
22
|
Fan W, Yanase T, Morinaga H, Mu YM, Nomura
M, Okabe T, Goto K, Harada N and Nawata H: Activation of peroxisome
proliferator-activated receptor-gamma and retinoid X receptor
inhibits aromatase transcription via nuclear factor-kappaB.
Endocrinology. 146:85–92. 2005. View Article : Google Scholar : PubMed/NCBI
|
23
|
Komar CM: Peroxisome
proliferator-activated receptors (PPARs) and ovarian
function-implications for regulating steroidogenesis,
differentiation, and tissue remodeling. Reprod Biol Endocrinol.
3:412005. View Article : Google Scholar : PubMed/NCBI
|
24
|
Komar CM, Braissant O, Wahli W and Curry
TE Jr: Expression and localization of PPARs in the rat ovary during
follicular development and the periovulatory period. Endocrinology.
142:48312001. View Article : Google Scholar : PubMed/NCBI
|
25
|
van Houten EL and Visser JA: Mouse models
to study polycystic ovary syndrome: A possible link between
metabolism and ovarian function. Reprod Biol. 14:32–43. 2014.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Lombardi LA, Simãμes RS, Maganhin CC,
Baracat MC, Silva-Sasso GR, Florencio-Silva R, Soares JM Jr and
Baracat EC: Immunohistochemical evaluation of proliferation,
apoptosis and steroidogenic enzymes in the ovary of rats with
polycystic ovary. Rev Assoc Med Bras (1992). 60:349–356. 2014.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Salilew-Wondim D, Wang Q, Tesfaye D,
Schellander K, Hoelker M, Hossain MM and Tsang BK: Polycystic
ovarian syndrome is accompanied by repression of gene signatures
associated with biosynthesis and metabolism of steroids,
cholesterol and lipids. J Ovarian Res. 8:242015. View Article : Google Scholar : PubMed/NCBI
|
28
|
Billig H, Furuta I and Hsueh AJ: Estrogens
inhibit and androgens enhance ovarian granulosa cell apoptosis.
Endocrinology. 133:2204–2212. 1993. View Article : Google Scholar : PubMed/NCBI
|
29
|
Goodman SB, Kugu K, Chen SH, Preutthipan
S, Tilly KI, Tilly JL and Dharmarajan AM: Estradiol-mediated
suppression of apoptosis in the rabbit corpus luteum is associated
with a shift in expression of bcl-2 family members favoring
cellular survival. Biol Reprod. 59:820–827. 1998. View Article : Google Scholar : PubMed/NCBI
|
30
|
Caligioni CS: Assessing reproductive
status/stages in mice. Curr Protoc Neurosci. 4:Appendix 4I. 2009.
View Article : Google Scholar : PubMed/NCBI
|
31
|
Yang JL, Zhang CP, Li L, Huang L, Ji SY,
Lu CL, Fan CH, Cai H, Ren Y, Hu ZY, et al: Testosterone induces
redistribution of forkhead box-3a and down-regulation of growth and
differentiation factor 9 messenger ribonucleic acid expression at
early stage of mouse folliculogenesis. Endocrinology. 151:774–782.
2010. View Article : Google Scholar : PubMed/NCBI
|
32
|
Capellino S, Straub RH and Cutolo M:
Aromatase and regulation of the estrogen-to-androgen ratio in
synovial tissue inflammation: Common pathway in both sexes. Ann N Y
Acad Sci. 1317:24–31. 2014. View Article : Google Scholar : PubMed/NCBI
|